No reaction with free IgE or the drug/immunoglobulin complex.
Used to measure omalizumab levels in patient serum.
Recommended antibody pair for PK assays: CABT-L0168Y - CABT-L0169Y.
Summary
Specifications
Antibody Isotype
IgG
Clone
B36
Immunogen
Omalizumab
Conjugate
Unconjugated
Applications
Application Notes
Suitable for use in ELISA. We recommend the following for sandwich ELISA (Capture - Detection): CABT-L0168Y - CABT-L0169Y Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.
General Notes
We recommend the following antibody pair to develop a pharmacokinetic (PK) assay: CABT-L0168Y - CABT-L0169Y CABT-L0168Y is recommended for use as a capture antibody when paired with CABT-L0169Y. Evolocumab (Repatha) is a fully human IgG2 lambda antibody. It is approved for the treatment of certain patients with high cholesterol and for preventing heart attacks and strokes. By inhibiting the binding of the PCSK9 protein to the low-density lipoprotein receptor (LDLR), the drug increases the availability of LDLRs, resulting in reduced LDL levels.
Citations
Publication ()
Have you cited CABT-L0168Y in a publication? Let us know and earn a reward for your research.
My Review for Human Anti-Omalizumab monoclonal antibody, clone B36
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.